Поиск | Myliveroom — Live Events & Online Communities

Rohit More добавлена новая статья Другое
2026-06-17 05:24:55 - Перевод -

Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease Treatment
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...

0 Комментарии 0 Поделились 187 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Atharva Inamke07 добавлена новая статья Health
2026-05-28 12:47:04 - Перевод -

Adalimumab Biosimilar market Insights Report: Innovation Trends and Business Strategies
" According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market The global adalimumab biosimilar market was valued at USD 598.30 million in 2022 and is expected to reach USD 3,431.48 million by 2030, at a CAGR of 24.4% during the forecast period. This Adalimumab Biosimilar Marketdocument provides with CAGR value fluctuation during the...

0 Комментарии 0 Поделились 651 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit More добавлена новая статья Другое
2026-06-12 10:28:29 - Перевод -

Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The large scale Adalimumab Biosimilar Marketing report...

0 Комментарии 0 Поделились 362 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!